Kuma Akihiro, Tamura Masahito, Ishimatsu Nana, Miyamoto Tetsu, Serino Ryota, Ishimori Shingo, Morisada Naoya, Iijima Kazumoto, Yamada Sohsuke, Takeuchi Masaaki, Abe Haruhiko, Otsuji Yutaka
The Second Department of Internal Medicine, School of Medicine, University of Occupational and Environmental Health, Japan.
Intern Med. 2015;54(6):631-5. doi: 10.2169/internalmedicine.54.3151. Epub 2015 Jan 15.
Uromodulin-associated kidney disease (UAKD) is an autosomal dominant disease caused by a mutation in the uromodulin (UMOD) gene, leading to end-stage renal disease. We herein report the case of a family with UAKD caused by a novel mutation (C135G) in the UMOD gene. A 31-year-old woman had a low estimated glomerular filtration rate (59.7 mL/min per 1.73 m(2)). Her father, grandfather and paternal aunt had received maintenance hemodialysis therapy since their 40's. This case underscores the importance of performing genetic testing in young patients even in cases involving only moderate abnormalities in the kidney function.
尿调节蛋白相关肾病(UAKD)是一种常染色体显性疾病,由尿调节蛋白(UMOD)基因突变引起,可导致终末期肾病。我们在此报告一个因UMOD基因新突变(C135G)导致UAKD的家族病例。一名31岁女性的估计肾小球滤过率较低(59.7 mL/分钟/1.73 m²)。她的父亲、祖父和姑姑自40多岁起就接受维持性血液透析治疗。该病例强调了即使在肾功能仅有中度异常的情况下,对年轻患者进行基因检测的重要性。